Niagen Bioscience CDXC Stock
Niagen Bioscience Price Chart
Niagen Bioscience CDXC Financial and Trading Overview
Niagen Bioscience stock price | 7.87 USD |
Previous Close | 1.74 USD |
Open | 1.72 USD |
Bid | 0 USD x 800 |
Ask | 0 USD x 1000 |
Day's Range | 1.65 - 1.77 USD |
52 Week Range | 1.15 - 2.28 USD |
Volume | 132.26K USD |
Avg. Volume | 105.13K USD |
Market Cap | 125.19M USD |
Beta (5Y Monthly) | 1.790492 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 5.17 USD |
CDXC Valuation Measures
Enterprise Value | 111.86M USD |
Trailing P/E | N/A |
Forward P/E | -27.833334 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.6185938 |
Price/Book (mrq) | 4.4652405 |
Enterprise Value/Revenue | 1.446 |
Enterprise Value/EBITDA | -9.487 |
Trading Information
Niagen Bioscience Stock Price History
Beta (5Y Monthly) | 1.790492 |
52-Week Change | 1.82% |
S&P500 52-Week Change | 20.43% |
52 Week High | 2.28 USD |
52 Week Low | 1.15 USD |
50-Day Moving Average | 1.47 USD |
200-Day Moving Average | 1.59 USD |
CDXC Share Statistics
Avg. Volume (3 month) | 105.13K USD |
Avg. Daily Volume (10-Days) | 96.45K USD |
Shares Outstanding | 74.97M |
Float | 47.76M |
Short Ratio | 20.28 |
% Held by Insiders | 41.87% |
% Held by Institutions | 15.56% |
Shares Short | 1.54M |
Short % of Float | 2.77% |
Short % of Shares Outstanding | 2.04% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:3 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -13.83% |
Operating Margin (ttm) | -16.63% |
Gross Margin | 59.19% |
EBITDA Margin | -15.24% |
Management Effectiveness
Return on Assets (ttm) | -15.070% |
Return on Equity (ttm) | -39.71% |
Income Statement
Revenue (ttm) | 77.35M USD |
Revenue Per Share (ttm) | 1.08 USD |
Quarterly Revenue Growth (yoy) | 30.69% |
Gross Profit (ttm) | 42.8M USD |
EBITDA | -11790000 USD |
Net Income Avi to Common (ttm) | -10702000 USD |
Diluted EPS (ttm) | -0.16 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 22.99M USD |
Total Cash Per Share (mrq) | 0.31 USD |
Total Debt (mrq) | 4.09M USD |
Total Debt/Equity (mrq) | 14.59 USD |
Current Ratio (mrq) | 2.528 |
Book Value Per Share (mrq) | 0.374 |
Cash Flow Statement
Operating Cash Flow (ttm) | -5108000 USD |
Levered Free Cash Flow (ttm) | -1725000 USD |
Profile of Niagen Bioscience
Country | United States |
State | CA |
City | Los Angeles |
Address | 10900 Wilshire Blvd |
ZIP | 90024 |
Phone | 310-388-6706 |
Website | https://www.chromadex.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 113 |
ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.
Q&A For Niagen Bioscience Stock
What is a current CDXC stock price?
Niagen Bioscience CDXC stock price today per share is 7.87 USD.
How to purchase Niagen Bioscience stock?
You can buy CDXC shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Niagen Bioscience?
The stock symbol or ticker of Niagen Bioscience is CDXC.
Which industry does the Niagen Bioscience company belong to?
The Niagen Bioscience industry is Biotechnology.
How many shares does Niagen Bioscience have in circulation?
The max supply of Niagen Bioscience shares is 77.75M.
What is Niagen Bioscience Price to Earnings Ratio (PE Ratio)?
Niagen Bioscience PE Ratio is 0.00000000 now.
What was Niagen Bioscience earnings per share over the trailing 12 months (TTM)?
Niagen Bioscience EPS is 0 USD over the trailing 12 months.
Which sector does the Niagen Bioscience company belong to?
The Niagen Bioscience sector is Healthcare.
Niagen Bioscience CDXC included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 15587.79 USD — |
-5.82
|
9.14B USD — | 15575.68 USD — | 16128.16 USD — | — - | 9.14B USD — |
NASDAQ Industrial INDS | 9888.95 USD — |
-5.72
|
— — | 9881.85 USD — | 10226.45 USD — | — - | — — |
NASDAQ Capital Market Composite RCMP | 92.16 USD — |
-4.45
|
— — | 89.57 USD — | 93.85 USD — | — - | — — |
NASDAQ HealthCare IXHC | 869.8 USD — |
-5.51
|
— — | 868.74 USD — | 900.72 USD — | — - | — — |
- {{ link.label }} {{link}}